SCYNEXIS INC (SCYX:NASDAQ)
$4.7 -0.21 (-4.277%)
Analysed SCYNEXIS INC (SCYX:NASDAQ) News Sources
SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
31-03-2026
yahoo.com
SCYNEXIS Announces $40.0 Million Private Placement
31-03-2026
yahoo.com
SCYNEXIS Enters $40 Million Private Placement, Completes Acquisition of PXL-770 to Treat Kidney Disease
31-03-2026
yahoo.com
SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
07-05-2026
yahoo.com
SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update
11-05-2026
yahoo.com
SCYNEXIS Announces One-for-Eight Reverse Stock Split
22-05-2026
yahoo.com
SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
30-06-2026
yahoo.com
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update
10-08-2026
yahoo.com
SCYNEXIS to Participate in Upcoming Investor Conferences
01-09-2026
yahoo.com
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer
10-09-2026
yahoo.com
What is the current price of SCYNEXIS INC (SCYX:NASDAQ)?
The current price of SCYNEXIS INC (SCYX:NASDAQ) is $4.7.
SCYNEXIS INC (SCYX:NASDAQ) absolute price change since previous trading day?
The absolute price change of SCYNEXIS INC (SCYX:NASDAQ) since the previous trading day is $-0.21.
SCYNEXIS INC (SCYX:NASDAQ) percentage price change since previous trading day?
The percentage price change of SCYNEXIS INC (SCYX:NASDAQ) since the previous trading day is -4.277%.
What is the most recent average sentiment score for SCYNEXIS INC (SCYX:NASDAQ)?
The most recent average sentiment score for SCYNEXIS INC (SCYX:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for SCYNEXIS INC (SCYX:NASDAQ)?
The most recent sentiment for SCYNEXIS INC (SCYX:NASDAQ) is .
SEC-8K** Filing Available For SCYNEXIS INC (SCYX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.